JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 12, Pages 2778-2788
Publisher
Oxford University Press (OUP)
Online
2013-09-25
DOI
10.1093/carcin/bgt318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- -Catulin Drives Metastasis by Activating ILK and Driving an v 3 Integrin Signaling Axis
- (2012) C.-H. Liang et al. CANCER RESEARCH
- A new era in the treatment of melanoma: from biology to clinical practice
- (2011) Iván Márquez-Rodas et al. Clinical & Translational Oncology
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway
- (2011) A A Wani et al. ONCOGENE
- The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction
- (2011) Jun Xie et al. PLoS One
- Prognostic Significance of Sox4 Expression in Human Cutaneous Melanoma and Its Role in Cell Migration and Invasion
- (2010) Seyed Mehdi Jafarnejad et al. AMERICAN JOURNAL OF PATHOLOGY
- Important role of integrins in the cancer biology
- (2010) R. Rathinam et al. CANCER AND METASTASIS REVIEWS
- Cell Cycle Regulator ING4 Is a Suppressor of Melanoma Angiogenesis That Is Regulated by the Metastasis Suppressor BRMS1
- (2010) J. Li et al. CANCER RESEARCH
- Integrins as therapeutic targets: lessons and opportunities
- (2010) Dermot Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer
- (2010) S M Pontier et al. ONCOGENE
- Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells
- (2009) Andrew L. Muranyi et al. EXPERIMENTAL HEMATOLOGY
- Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
- (2009) Ahlame Saidi et al. INTERNATIONAL JOURNAL OF CANCER
- Integrin αvβ3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription
- (2009) Daniela Lössner et al. JOURNAL OF CELLULAR PHYSIOLOGY
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- JWA regulates melanoma metastasis by integrin αVβ3 signaling
- (2009) J Bai et al. ONCOGENE
- Current management of metastatic melanoma
- (2008) V. A. Trinh AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression
- (2008) Alison M. Karst et al. INTERNATIONAL JOURNAL OF CANCER
- Integrin-linked kinase - essential roles in physiology and cancer biology
- (2008) P. C. McDonald et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation